<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03475173</url>
  </required_header>
  <id_info>
    <org_study_id>201611825</org_study_id>
    <nct_id>NCT03475173</nct_id>
  </id_info>
  <brief_title>New Non-invasive Modalities for Assessing Retinal Structure and Function</brief_title>
  <official_title>New Non-invasive Modalities for Assessing Retinal Structure and Function:Preliminary Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Randy Kardon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates a new technology to assess the structure and function inside the eye.
      Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal
      structure and function compared to other visual function tests.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2014</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Blood Flow</measure>
    <time_frame>1 day</time_frame>
    <description>imaging the movement of blood through blood vessels in retina and optic nerve</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ischemic Optic Neuropathy</condition>
  <condition>Branch Retinal Artery Occlusion</condition>
  <condition>Hemianopia</condition>
  <condition>Leber Hereditary Optic Neuropathy</condition>
  <condition>Acute Zonal Occult Outer Retinopathy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LSFG-NAVI</intervention_name>
    <description>laser-speckle blood flow of ocular arteries and veins</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Controls:

        Inclusion:

        Normal eye exam in last 2 years

        Exclusion:

        Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are
        okay. Any abnormalities of the retina or optic nerve that could affect metabolism of the
        retina outside of normal.

        Subjects with Inner Retina Defect:

        Inclusion:

        Defined structural defect to include those with Ischemic optic neuropathy, branch retinal
        artery occlusion (BRAO), hemianopia or visual field defect that respects the vertical
        meridian, inherited mitochondrial optic neuropathies such as Leber's and Dominant Optic
        Neuropathy, other retinopathies or optic neuropathies.

        Exclusion:

        Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are
        okay.

        Subjects with Outer Retinal Defect:

        Inclusion:

        AZOOR (acute zonal occult outer retinopathy) or other focal or diffuse outer photoreceptor
        loss of function

        Exclusion:

        Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are
        okay.

        The 450 total is to allow for exclusion of some subjects or in the event that the enrolled
        subject blinks too much or cannot fixate on a visual target adequately to maintain the same
        eye position during the short imaging interval. We hope to have a total of 450 (50 controls
        and 400 patients)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy H Kardon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa Department of Ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie K Nellis, BSN</last_name>
    <phone>319-356-8299</phone>
    <email>julie-nellis@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan M Full, BSN</last_name>
    <phone>319-356-8299</phone>
    <email>jan-full@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa Department of Ophthalmology</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise L Rettig, MHA. MBA</last_name>
      <phone>319-356-2866</phone>
      <phone_ext>5849</phone_ext>
      <email>denise-rettig@uiowa.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Kardon</investigator_full_name>
    <investigator_title>Dr. Randy Kardon M.D. Ph.D Professor and Director of Neuro-ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Optic Neuropathy</keyword>
  <keyword>, Retinopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Optic Neuropathy, Ischemic</mesh_term>
    <mesh_term>Optic Atrophy, Hereditary, Leber</mesh_term>
    <mesh_term>Retinal Artery Occlusion</mesh_term>
    <mesh_term>Hemianopsia</mesh_term>
    <mesh_term>Scotoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

